Trends, Tips From 7 Years Of EPO Antibody Patent Appeals
Since the first monoclonal antibody approval by the U.S. Food and Drug Administration in 1986, which was for Muromonab-CD3, these drugs have become progressively more common, frequently reaching blockbuster status. According to a March report...To view the full article, register now.
Already a subscriber? Click here to view full article